This feature highlights the latest cohort of University of Houston’s Innov8Hub, a 12-week accelerator program helping faculty, students, and researchers turn breakthrough ideas into real-world ventures. From biotech and AI to clean energy and advanced rehabilitation tools, the story showcases the bold innovations—and the determined entrepreneurs—shaping the future through mentorship, market insight, and a final investor-ready pitch.

Macaw UAS founder Alexandra Ulinski is advancing prototype development and pursuing strategic partnerships following her second-place finish at UH’s Fall 2024 Innov8Hub Pitch Day. The story highlights her work on a modular drone platform for air quality monitoring and its potential applications across research, emergency response, and industry.

UH Tech Bridge member Indapta Therapeutics has secured $22.5 million to advance clinical trials of its lead g-NK cell therapy, IDP-023, for cancer and autoimmune diseases. Backed by major investors and a $4.5 million CPRIT grant, Indapta’s progress reflects the strength of UH’s innovation ecosystem in driving biotech breakthroughs.